Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Experimental Rhinovirus Infection in Healthy Volunteers
NCT03508479Phase 1Withdrawn
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Dec 2024
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by University of North Carolina at Chapel Hill. Primary endpoint: Change in neutrophils/mL in nasal lavage fluid. Planned start Dec 2024; status: withdrawn.
Beyond the preview
Go deeper on NCT03508479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03508479.